Source link : https://newshealth.biz/health-news/fda-oks-therapy-for-deadly-pediatric-immune-disorder/
The FDA on Thursday granted accelerated approval to marnetegragene autotemcel (Kresladi) as the first gene therapy for treating kids with severe leukocyte adhesion deficiency type I (LAD-I), an ultra-rare inherited immune deficiency. Approval stipulates use in LAD-I cases caused by biallelic variants in the ITGB2 gene and in which no human leukocyte antigen (HLA)-matched sibling […]
The post FDA OKs Therapy for Deadly Pediatric Immune Disorder first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-27 16:37:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8